1
|
Suzuki K, Watanabe I, Tachibana T, Mori K, Ishikawa K, Ishibashi T, Uchio E, Sonoda KH, Hisatomi T. Development of in situ crosslinked hyaluronan as an adjunct to vitrectomy surgery. JOURNAL OF MATERIALS SCIENCE. MATERIALS IN MEDICINE 2023; 34:56. [PMID: 37930485 PMCID: PMC10628021 DOI: 10.1007/s10856-023-06757-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Accepted: 10/02/2023] [Indexed: 11/07/2023]
Abstract
Ophthalmologists have used hyaluronan (HA) products as adjuncts to ocular surgery since the 1970s. However, HA products are not always functional in surgeries of the posterior eye segment due to their lack of biomechanical strength. In this study, we developed an in situ crosslinked HA (XL-HA) and evaluated its potential as an adjunct to vitrectomy surgery in an in vitro model with a triamcinolone acetonide (TA) layer used as a pseudo residual vitreous cortex (RVC). Within a few minutes at concentrations over 0.9%, XL-HA, generated by the click chemistry of HA-dibenzocyclooctyne and HA-azidoethylamine, formed a hydrogel with the appropriate hardness for tweezers peeling. XL-HA (concentration, 0.76-1.73%) without dispersion successfully entered the TA layer and removed more than 45% of the total TA. Dynamic viscoelasticity helps to explain the rheological behavior of hydrogels, and the assessment results for XL-HA indicated that suitable concentrations were between 0.97% and 1.30%. For example, 1.30% XL-HA hydrogel reached sufficient hardness at 3 min for tweezers peeling, and the TA removal ability exceeded 70%. These results demonstrated that XL-HA was a potential adjunct to successful vitrectomy.
Collapse
Affiliation(s)
- Kiyoshi Suzuki
- Central Research Laboratories, Seikagaku Corporation, 1253, Tateno 3-chome, Higashiyamato-shi, Tokyo, 207-0021, Japan
| | - Ippei Watanabe
- Central Research Laboratories, Seikagaku Corporation, 1253, Tateno 3-chome, Higashiyamato-shi, Tokyo, 207-0021, Japan
- Medical Affairs, Seikagaku Corporation, 1-6-1 Marunouchi, Chiyoda-ku, Tokyo, 100-0005, Japan
| | - Takashi Tachibana
- Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan
| | - Kenichiro Mori
- Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan
| | - Keijiro Ishikawa
- Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan
| | - Tatsuro Ishibashi
- Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan
| | - Eiichi Uchio
- Department of Ophthalmology, Faculty of Medicine, Fukuoka University, 8-19-1, Nanakuma, Fukuoka Jonan-ku, Fukuoka, 814-080, Japan
| | - Koh-Hei Sonoda
- Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan
| | - Toshio Hisatomi
- Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, 3-1-1, Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
- Department of Ophthalmology, Faculty of Medicine, Fukuoka University, 8-19-1, Nanakuma, Fukuoka Jonan-ku, Fukuoka, 814-080, Japan.
- Department of Ophthalmology, Fukuoka University Chikushi Hospital, 1-1-1 Zokumyoin, Chikushino-shi, Fukuoka, 818-8502, Japan.
| |
Collapse
|
2
|
Hydrogel, Electrospun and Composite Materials for Bone/Cartilage and Neural Tissue Engineering. MATERIALS 2021; 14:ma14226899. [PMID: 34832300 PMCID: PMC8624846 DOI: 10.3390/ma14226899] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/04/2021] [Revised: 11/09/2021] [Accepted: 11/11/2021] [Indexed: 12/15/2022]
Abstract
Injuries of the bone/cartilage and central nervous system are still a serious socio-economic problem. They are an effect of diversified, difficult-to-access tissue structures as well as complex regeneration mechanisms. Currently, commercially available materials partially solve this problem, but they do not fulfill all of the bone/cartilage and neural tissue engineering requirements such as mechanical properties, biochemical cues or adequate biodegradation. There are still many things to do to provide complete restoration of injured tissues. Recent reports in bone/cartilage and neural tissue engineering give high hopes in designing scaffolds for complete tissue regeneration. This review thoroughly discusses the advantages and disadvantages of currently available commercial scaffolds and sheds new light on the designing of novel polymeric scaffolds composed of hydrogels, electrospun nanofibers, or hydrogels loaded with nano-additives.
Collapse
|
3
|
Yang Y, Yang G, Liu X, Xu Y, Zhao S, Zhang W, Xu M. Construction of Lung Tumor Model for Drug Screening Based on 3D Bio-Printing Technology. J BIOMATER TISS ENG 2021. [DOI: 10.1166/jbt.2021.2706] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
As is known to all, the biological characteristics of two-dimensional (2D) cultured cells are quite different from those in vivo, so the 2D screening model can no longer meet people’s needs. With the development of tissue engineering, people are committed to developing 3D tissue
models that can better reflect the biology in vivo, and tend to be mass and miniaturized. In this study, three-dimensional (3D) bio-printing was used to develop an appropriate 3D model for screening sensitive anti-lung cancer drugs in vitro. A549 lung cancer cells were mixed with 8% sodium
alginate and 5% gelatin as bio-printing ink to fabricate a cell-laden hydrogel grid scaffold structure. The sensitivity of the printed 3D model to drugs was evaluated with eight anti-tumor traditional Chinese medicines. A fluorescent live/dead staining was carried out at different time to
assess the cell survival rate in the 3D scaffolds. MTT assay was used to determine the inhibitory rate of eight antitumor traditional Chinese medicines on A549 cell proliferation in 3D-printed lung tumor models and conventional 2D culture models.
Collapse
Affiliation(s)
- Yadong Yang
- Institute of Bioengineering, Hangzhou Medical College, 182 Tian Mu Shan Road, Hangzhou 310013, Zhejiang Province, China
| | - Geng Yang
- Institute of Bioengineering, Hangzhou Medical College, 182 Tian Mu Shan Road, Hangzhou 310013, Zhejiang Province, China
| | - Xingzhu Liu
- Institute of Bioengineering, Hangzhou Medical College, 182 Tian Mu Shan Road, Hangzhou 310013, Zhejiang Province, China
| | - Yimeng Xu
- Institute of Bioengineering, Hangzhou Medical College, 182 Tian Mu Shan Road, Hangzhou 310013, Zhejiang Province, China
| | - Siyu Zhao
- Institute of Bioengineering, Hangzhou Medical College, 182 Tian Mu Shan Road, Hangzhou 310013, Zhejiang Province, China
| | - Wenyuan Zhang
- Institute of Bioengineering, Hangzhou Medical College, 182 Tian Mu Shan Road, Hangzhou 310013, Zhejiang Province, China
| | - Mengjiao Xu
- Institute of Bioengineering, Hangzhou Medical College, 182 Tian Mu Shan Road, Hangzhou 310013, Zhejiang Province, China
| |
Collapse
|
4
|
Lammi MJ, Piltti J, Prittinen J, Qu C. Challenges in Fabrication of Tissue-Engineered Cartilage with Correct Cellular Colonization and Extracellular Matrix Assembly. Int J Mol Sci 2018; 19:E2700. [PMID: 30208585 PMCID: PMC6164936 DOI: 10.3390/ijms19092700] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2018] [Revised: 09/07/2018] [Accepted: 09/09/2018] [Indexed: 12/12/2022] Open
Abstract
A correct articular cartilage ultrastructure regarding its structural components and cellularity is important for appropriate performance of tissue-engineered articular cartilage. Various scaffold-based, as well as scaffold-free, culture models have been under development to manufacture functional cartilage tissue. Even decellularized tissues have been considered as a potential choice for cellular seeding and tissue fabrication. Pore size, interconnectivity, and functionalization of the scaffold architecture can be varied. Increased mechanical function requires a dense scaffold, which also easily restricts cellular access within the scaffold at seeding. High pore size enhances nutrient transport, while small pore size improves cellular interactions and scaffold resorption. In scaffold-free cultures, the cells assemble the tissue completely by themselves; in optimized cultures, they should be able to fabricate native-like tissue. Decellularized cartilage has a native ultrastructure, although it is a challenge to obtain proper cellular colonization during cell seeding. Bioprinting can, in principle, provide the tissue with correct cellularity and extracellular matrix content, although it is still an open question as to how the correct molecular interaction and structure of extracellular matrix could be achieved. These are challenges facing the ongoing efforts to manufacture optimal articular cartilage.
Collapse
Affiliation(s)
- Mikko J Lammi
- Key Laboratory of Trace Elements and Endemic Diseases, National Health and Family Planning, Institute of Endemic Diseases, School of Public Health of Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China.
- Department of Integrative Medical Biology, University of Umeå, 901 87 Umeå, Sweden.
| | - Juha Piltti
- Department of Integrative Medical Biology, University of Umeå, 901 87 Umeå, Sweden.
- Nordlab Kokkola, Keski-Pohjanmaa Central Hospital Soite, 40620 Kokkola, Finland.
| | - Juha Prittinen
- Department of Integrative Medical Biology, University of Umeå, 901 87 Umeå, Sweden.
| | - Chengjuan Qu
- Department of Integrative Medical Biology, University of Umeå, 901 87 Umeå, Sweden.
| |
Collapse
|